Molecular Data Inc. (NASDAQ:MKD) price on Friday, August 27, fall -0.06% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.41.
A look at the stock’s price movement, the level at last check in today’s session was $0.41, moving within a range at $0.4004 and $0.4249. Turning to its 52-week performance, $2.23 and $0.37 were the 52-week high and 52-week low respectively. Overall, MKD moved -30.94% over the past month.
Molecular Data Inc.’s market cap currently stands at around $57.59 million, with investors looking forward to this quarter’s earnings report slated for Mar 25, 2020.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that MKD is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
MKD’s current price about -21.28% and -42.02% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 24.12, while 7-day volatility ratio is 10.10% and 9.58% in the 30-day chart. Further, Molecular Data Inc. (MKD) has a beta value of 0, and an average true range (ATR) of 0.05.
In the market, a comparison of Molecular Data Inc. (MKD) and its peers suggest the former has performed considerably weaker. Data shows MKD’s intraday price has changed -0.06% today and -73.10% over the past year. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are up 0.80% and 0.64% respectively on the day as seen in early trades.
If we refocus on Molecular Data Inc. (NASDAQ:MKD), historical trading data shows that trading volumes averaged 2.14 million over the past 10 days and 1.38 million over the past 3 months. The company’s latest data on shares outstanding shows there are 116.90 million shares.
The 10.08% of Molecular Data Inc.’s shares are in the hands of company insiders while institutional holders own 4.50% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.78 million on May 27, 2021, giving us a short ratio of 1.26. The data shows that as of May 27, 2021 short interest in Molecular Data Inc. (MKD) stood at 0.56% of shares outstanding, with shares short falling to 1.64 million registered in Apr 29, 2021. Current price change has pushed the stock -51.01% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the MKD stock continues to rise going into the next quarter.